NCM
BPMC

Nearwater Capital Markets’s Blueprint Medicines BPMC Stock Holding History

Nearwater Capital Markets’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-160,000
Closed -$20.5M – 146
2025
Q2 		$20.5M Buy
+160,000
New +$16.6M 0.33% 58

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nearwater Capital Markets's BPMC Position: Q3 2025 in Review

Nearwater Capital Markets sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 160,000 shares — an estimated $20.5M sold.

Nearwater Capital Markets first reported a position in BPMC in Q2 2025 and held it in 1 quarter. The position peaked at $20.5M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Nearwater Capital Markets reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Nearwater Capital Markets sold 160,000 Blueprint Medicines shares in Q3 2025, an estimated $20.5M.
  • Nearwater Capital Markets first reported a position in Blueprint Medicines in Q2 2025 and held it in 1 quarter.
  • Nearwater Capital Markets's Blueprint Medicines position peaked at $20.5M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Nearwater Capital Markets's 13F filing for Q3 2025, filed 13 Nov 2025.